title: Pluripotent stem cell based gene therapy for hematological diseases.
abstract: Standard treatment for severe inherited hematopoietic diseases consists of allogeneic stem cell transplantation. Alternatively, patients can be treated with gene therapy: gene-corrected autologous hematopoietic stem and progenitor cells (HSPC) are transplanted. By using retro- or lentiviral vectors, a copy of the functional gene is randomly inserted in the DNA of the HSPC and becomes constitutively expressed. Gene therapy is currently limited to monogenic diseases for which clinical trials are being actively conducted in highly specialized centers around the world. This approach, although successful, carries with it inherent safety and efficacy issues. Recently, two technologies became available that, when combined, may enable treatment of genetic defects by HSPC that have the non-functional allele replaced by a functional copy. One technology consists of the generation of induced pluripotent stem cells (iPSC) from patient blood samples or skin biopsies, the other concerns nuclease-mediated gene editing. Both technologies have been successfully combined in basic research and appear applicable in the clinic. This paper reviews recent literature, discusses what can be achieved in the clinic using present knowledge and points out further research directions.
authors.affiliation: Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Belgium.
authors.forename: Stijn
authors.initials: S
authors.lastname: Vanhee
authors.affiliation: Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Belgium. Electronic address: Bart.Vandekerckhove@UGent.be.
authors.forename: Bart
authors.initials: B
authors.lastname: Vandekerckhove
mesh_terms: D000072669:Gene Editing / Q000379:methods*; D015316:Genetic Therapy / Q000379:methods*; D006402:Hematologic Diseases / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000637:transplantation; D016086:Lentivirus
keywords: Gene therapy; Hematological diseases; Hematopoiesis; IPSC; Pluripotent stem cells; Stem cells; Tailored nucleases; hESC